agilon health (AGL) Stock Forecast, Price Target & Predictions
AGL Stock Forecast
agilon health stock forecast is as follows: an average price target of $5.50 (represents a 51.10% upside from AGL’s last price of $3.64) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
AGL Price Target
The average price target for agilon health (AGL) is $5.50 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $6.50 to $4.00. This represents a potential 51.10% upside from AGL's last price of $3.64.
AGL Analyst Ratings
According to 11 Wall Street analysts, agilon health's rating consensus is 'Buy'. The analyst rating breakdown for AGL stock is 0 'Strong Buy' (0.00%), 6 'Buy' (54.55%), 5 'Hold' (45.45%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
agilon health Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 08, 2024 | George Hill | Deutsche Bank | $4.00 | $5.60 | -28.57% | 9.89% |
| May 29, 2024 | Michael Ha | Robert W. Baird | $6.00 | $5.76 | 4.17% | 64.84% |
| May 24, 2024 | Jailendra Singh | Truist Financial | $6.50 | $5.65 | 15.04% | 78.57% |
| Jul 26, 2022 | David MacDonald | Truist Financial | $33.00 | $25.13 | 31.32% | 806.59% |
The latest agilon health stock forecast, released on Aug 08, 2024 by George Hill from Deutsche Bank, set a price target of $4.00, which represents a -28.57% decrease from the stock price at the time of the forecast ($5.60), and a 9.89% increase from AGL last price ($3.64).
agilon health Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 3 |
| Avg Price Target | - | $4.00 | $5.50 |
| Last Closing Price | $3.64 | $3.64 | $3.64 |
| Upside/Downside | -100.00% | 9.89% | 51.10% |
In the current month, the average price target of agilon health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to agilon health's last price of $3.64. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 08, 2024 | Deutsche Bank | Hold | Hold | Hold |
| Aug 05, 2024 | Cowen & Co. | Hold | Hold | Hold |
| May 08, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Oct 20, 2023 | BTIG | - | Neutral | Initialise |
| Oct 20, 2023 | Exane BNP Paribas | - | Neutral | Initialise |
| Oct 20, 2023 | BNP Paribas | - | Neutral | Initialise |
| Oct 20, 2023 | Citigroup | - | Buy | Initialise |
| Oct 20, 2023 | Benchmark | - | Buy | Initialise |
| Oct 20, 2023 | UBS | - | Buy | Initialise |
| Nov 04, 2022 | SVB Leerink | Outperform | Outperform | Hold |
agilon health's last stock rating was published by Deutsche Bank on Aug 08, 2024. The company gave AGL a "Hold" rating, the same as its previous rate.
agilon health Financial Forecast
agilon health Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.06B | $1.22B | $1.15B | $1.14B | $689.77M | $694.86M | - | $653.45M | $462.89M | $458.61M | $498.96M | $413.10M |
| Avg Forecast | $2.30B | $2.30B | $2.29B | $2.31B | $1.82B | $1.82B | $1.83B | $1.92B | $1.47B | $1.47B | $1.54B | $1.61B | $1.04B | $1.13B | $1.11B | $1.08B | $662.01M | $662.21M | $647.79M | $642.87M | $452.95M | $450.52M | $473.20M | $405.86M |
| High Forecast | $2.31B | $2.31B | $2.31B | $2.32B | $1.83B | $1.83B | $1.84B | $1.94B | $1.48B | $1.48B | $1.55B | $1.62B | $1.06B | $1.14B | $1.12B | $1.08B | $665.96M | $666.16M | $647.79M | $651.76M | $459.21M | $456.74M | $479.74M | $411.47M |
| Low Forecast | $2.29B | $2.29B | $2.29B | $2.30B | $1.81B | $1.81B | $1.83B | $1.92B | $1.46B | $1.47B | $1.54B | $1.61B | $1.02B | $1.13B | $1.11B | $1.07B | $659.90M | $660.10M | $647.79M | $610.78M | $430.34M | $428.02M | $449.57M | $385.60M |
| # Analysts | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 4 | 8 | 6 | 5 | 5 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.07% | 1.04% | 1.05% | 1.04% | 1.05% | - | 1.02% | 1.02% | 1.02% | 1.05% | 1.02% |
agilon health's average Quarter revenue forecast for Mar 24 based on 9 analysts is $1.61B, with a low forecast of $1.61B, and a high forecast of $1.62B. AGL's average Quarter revenue forecast represents a 52.76% increase compared to the company's last Quarter revenue of $1.06B (Dec 23).
agilon health EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 4 | 8 | 6 | 5 | 5 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-228.01M | $-29.03M | $-13.94M | $20.11M | $-62.22M | $-25.49M | - | $4.90M | $-57.62M | $-30.78M | $-293.30M | $-8.64M |
| Avg Forecast | $-187.56M | $-187.61M | $-187.07M | $-188.30M | $-148.25M | $-148.42M | $-149.31M | $-156.87M | $-119.60M | $-120.08M | $-125.71M | $-131.55M | $-84.51M | $-92.53M | $-90.44M | $-87.89M | $-53.98M | $-42.83M | $-52.82M | $-52.42M | $-36.94M | $-33.86M | $-234.64M | $-6.81M |
| High Forecast | $-186.96M | $-187.01M | $-186.48M | $-187.70M | $-147.78M | $-147.95M | $-148.83M | $-156.37M | $-119.21M | $-119.69M | $-125.31M | $-131.13M | $-82.90M | $-92.24M | $-90.15M | $-87.61M | $-53.81M | $-34.27M | $-52.82M | $-49.81M | $-35.09M | $-27.09M | $-187.71M | $-5.45M |
| Low Forecast | $-188.68M | $-188.73M | $-188.19M | $-189.43M | $-149.14M | $-149.31M | $-150.20M | $-157.81M | $-120.31M | $-120.89M | $-126.46M | $-132.34M | $-86.12M | $-93.08M | $-90.98M | $-88.42M | $-54.31M | $-51.40M | $-52.82M | $-53.15M | $-37.45M | $-40.63M | $-281.57M | $-8.17M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.70% | 0.31% | 0.15% | -0.23% | 1.15% | 0.60% | - | -0.09% | 1.56% | 0.91% | 1.25% | 1.27% |
9 analysts predict AGL's average Quarter EBITDA for Jun 23 to be $-90.44M, with a high of $-90.15M and a low of $-90.98M. This is -549.71% lower than agilon health's previous annual EBITDA (Mar 23) of $20.11M.
agilon health Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 4 | 8 | 6 | 5 | 5 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-230.48M | $-31.48M | $-16.80M | $16.02M | $-56.05M | $-30.50M | - | $726.00K | $-57.07M | $-35.84M | $-298.85M | $-15.08M |
| Avg Forecast | $-45.21M | $-38.87M | $-8.63M | $62.99M | $-49.43M | $-31.22M | $-19.87M | $15.34M | $-64.93M | $-40.49M | $-28.91M | $-5.21M | $-113.91M | $-22.35M | $-7.51M | $14.39M | $-39.95M | $-49.88M | $-6.85M | $-246.73K | $-42.88M | $-39.43M | $-239.08M | $-11.88M |
| High Forecast | $-45.02M | $-38.71M | $-8.60M | $63.48M | $-49.23M | $-31.09M | $-19.79M | $15.46M | $-64.66M | $-24.29M | $-28.79M | $-5.19M | $-61.02M | $-22.25M | $-7.48M | $14.51M | $-39.79M | $-39.90M | $-6.85M | $-230.72K | $-40.10M | $-31.54M | $-191.26M | $-9.50M |
| Low Forecast | $-45.56M | $-39.17M | $-8.70M | $62.73M | $-49.82M | $-31.46M | $-20.03M | $15.28M | $-65.43M | $-52.63M | $-29.14M | $-5.25M | $-138.32M | $-22.52M | $-7.57M | $14.34M | $-40.26M | $-59.85M | $-6.85M | $-251.16K | $-43.65M | $-47.31M | $-286.89M | $-14.26M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.02% | 1.41% | 2.24% | 1.11% | 1.40% | 0.61% | - | -2.94% | 1.33% | 0.91% | 1.25% | 1.27% |
agilon health's average Quarter net income forecast for Jun 23 is $-7.51M, with a range of $-7.57M to $-7.48M. AGL's average Quarter net income forecast represents a -146.88% decrease compared to the company's last Quarter net income of $16.02M (Mar 23).
agilon health SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 4 | 8 | 6 | 5 | 5 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $64.70M | $74.14M | $81.50M | $66.66M | $75.21M | $51.98M | - | $39.83M | $53.84M | $46.64M | $317.56M | $37.78M |
| Avg Forecast | $304.94M | $305.03M | $304.16M | $306.15M | $241.04M | $241.32M | $242.75M | $255.05M | $194.45M | $195.23M | $204.39M | $213.89M | $137.40M | $150.44M | $147.04M | $142.90M | $87.77M | $64.90M | $85.89M | $85.23M | $60.05M | $51.31M | $254.05M | $29.76M |
| High Forecast | $306.76M | $306.85M | $305.97M | $307.98M | $242.47M | $242.76M | $244.20M | $256.57M | $195.61M | $196.55M | $205.61M | $215.17M | $140.02M | $151.34M | $147.92M | $143.76M | $88.30M | $77.88M | $85.89M | $86.41M | $60.88M | $61.57M | $304.86M | $35.72M |
| Low Forecast | $303.97M | $304.06M | $303.19M | $305.18M | $240.27M | $240.55M | $241.98M | $254.24M | $193.83M | $194.60M | $203.74M | $213.21M | $134.79M | $149.96M | $146.57M | $142.45M | $87.49M | $51.92M | $85.89M | $80.98M | $57.05M | $41.05M | $203.24M | $23.81M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.47% | 0.49% | 0.55% | 0.47% | 0.86% | 0.80% | - | 0.47% | 0.90% | 0.91% | 1.25% | 1.27% |
agilon health's average Quarter SG&A projection for Mar 24 is $213.89M, based on 9 Wall Street analysts, with a range of $213.21M to $215.17M. The forecast indicates a 230.61% rise compared to AGL last annual SG&A of $64.70M (Dec 23).
agilon health EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 4 | 8 | 6 | 5 | 5 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.57 | $-0.08 | $-0.04 | $0.04 | $-0.14 | $-0.07 | - | - | $-0.14 | $-0.09 | $-0.79 | $-0.04 |
| Avg Forecast | $-0.11 | $-0.09 | $-0.02 | $0.15 | $-0.12 | $-0.08 | $-0.05 | $0.04 | $-0.16 | $-0.10 | $-0.07 | $-0.01 | $-0.28 | $-0.05 | $-0.02 | $0.04 | $-0.10 | $-0.05 | $-0.02 | $-0.00 | $-0.11 | $-0.09 | $-0.05 | $-0.03 |
| High Forecast | $-0.11 | $-0.09 | $-0.02 | $0.15 | $-0.12 | $-0.08 | $-0.05 | $0.04 | $-0.16 | $-0.06 | $-0.07 | $-0.01 | $-0.15 | $-0.05 | $-0.02 | $0.04 | $-0.10 | $-0.04 | $-0.02 | $-0.00 | $-0.10 | $-0.08 | $-0.05 | $-0.03 |
| Low Forecast | $-0.11 | $-0.10 | $-0.02 | $0.15 | $-0.12 | $-0.08 | $-0.05 | $0.04 | $-0.16 | $-0.13 | $-0.07 | $-0.01 | $-0.34 | $-0.05 | $-0.02 | $0.03 | $-0.10 | $-0.05 | $-0.02 | $-0.00 | $-0.11 | $-0.09 | $-0.05 | $-0.03 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.06% | 1.43% | 2.24% | 1.14% | 1.44% | 1.65% | - | -2.97% | 1.33% | 1.06% | 14.88% | 1.32% |
According to 9 Wall Street analysts, agilon health's projected average Quarter EPS for Jun 23 is $-0.02, with a low estimate of $-0.02 and a high estimate of $-0.02. This represents a -145.66% decrease compared to AGL previous annual EPS of $0.04 (Mar 23).
agilon health Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| MODV | ModivCare | $13.46 | $25.33 | 88.19% | Buy |
| SGRY | Surgery Partners | $31.38 | $47.50 | 51.37% | Buy |
| AGL | agilon health | $3.64 | $5.50 | 51.10% | Buy |
| HCSG | Healthcare Services Group | $11.53 | $17.33 | 50.30% | Hold |
| AMED | Amedisys | $97.37 | $143.38 | 47.25% | Hold |
| EHAB | Enhabit | $8.00 | $10.25 | 28.13% | Hold |
| INNV | InnovAge | $5.95 | $6.80 | 14.29% | Hold |
| ACHC | Acadia Healthcare Company | $77.77 | $84.89 | 9.16% | Buy |
| EHC | Encompass Health | $91.32 | $93.17 | 2.03% | Buy |
| ADUS | Addus HomeCare | $132.47 | $123.00 | -7.15% | Buy |
| UHS | Universal Health Services | $232.28 | $208.47 | -10.25% | Hold |
| PNTG | Pennant Group | $34.67 | $30.67 | -11.54% | Buy |
| ENSG | Ensign Group | $152.03 | $124.40 | -18.17% | Buy |
AGL Forecast FAQ
Is agilon health a good buy?
Yes, according to 11 Wall Street analysts, agilon health (AGL) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 54.55% of AGL's total ratings.
What is AGL's price target?
agilon health (AGL) average price target is $5.5 with a range of $4 to $6.5, implying a 51.10% from its last price of $3.64. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will agilon health stock go up soon?
According to Wall Street analysts' prediction for AGL stock, the company can go up by 51.10% (from the last price of $3.64 to the average price target of $5.5), up by 78.57% based on the highest stock price target, and up by 9.89% based on the lowest stock price target.
Can agilon health stock reach $5?
AGL's average twelve months analyst stock price target of $5.5 supports the claim that agilon health can reach $5 in the near future.
What are agilon health's analysts' financial forecasts?
agilon health's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $7.39B (high $7.44B, low $7.37B), average EBITDA is $-603M (high $-601M, low $-606M), average net income is $-85.182M (high $-84.646M, low $-86.025M), average SG&A $980.16M (high $986M, low $977.03M), and average EPS is $-0.207 (high $-0.206, low $-0.209). AGL's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $9.2B (high $9.26B, low $9.17B), average EBITDA is $-751M (high $-748M, low $-755M), average net income is $-29.724M (high $-28.848M, low $-30.705M), average SG&A $1.22B (high $1.23B, low $1.22B), and average EPS is $-0.0723 (high $-0.0701, low $-0.0747).
Did the AGL's actual financial results beat the analysts' financial forecasts?
Based on agilon health's last annual report (Dec 2023), the company's revenue was $4.32B, which missed the average analysts forecast of $4.36B by -0.95%. Apple's EBITDA was $-254M, missing the average prediction of $-355M by -28.47%. The company's net income was $-263M, beating the average estimation of $-129M by 103.13%. Apple's SG&A was $285.76M, missing the average forecast of $577.79M by -50.54%. Lastly, the company's EPS was $-0.64, beating the average prediction of $-0.315 by 103.45%. In terms of the last quarterly report (Dec 2023), agilon health's revenue was $1.06B, beating the average analysts' forecast of $1.04B by 1.90%. The company's EBITDA was $-228M, beating the average prediction of $-84.511M by 169.80%. agilon health's net income was $-230M, beating the average estimation of $-114M by 102.33%. The company's SG&A was $64.7M, missing the average forecast of $137.4M by -52.92%. Lastly, the company's EPS was $-0.57, beating the average prediction of $-0.277 by 105.79%